← Back
Kala Bio
KALA · listed on Nasdaq · worth $3.44 million
$0.1781
+2.95% on Nov 4
No insider bought or sold Kala Bio stock on the market in the last year.
No insider trades or company news in this range.
Reverse split 1-for-50 in May 2026. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what KALA ever actually traded at. The drop is real, but those huge old numbers aren't.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
19.3M shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
No insider bought or sold Kala Bio stock on the market in the last year. The reports below are share awards and other paperwork.
Big investors
People and funds that reported owning 5% or more of Kala Bio, newest first.
All reports
Every insider trade and SEC report we hold for Kala Bio.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 24, 2025SoldMary ReumuthOct 24, 2025 · Traded Oct 23, 2025 · CHIEF FINANCIAL OFFICER967 @ $0.8200$792.94
Oct 24, 2025SoldDarius KharabiOct 24, 2025 · Traded Oct 22, 2025 · CHIEF BUSINESS OFFICER20,806 @ $0.8300$17.3K
Oct 24, 2025SoldMary ReumuthOct 24, 2025 · Traded Oct 22, 2025 · CHIEF FINANCIAL OFFICER32,230 @ $0.8300$26.8K
Oct 24, 2025SoldRomulus K. BrazzellOct 24, 2025 · Traded Oct 22, 2025 · SEE REMARKS46,748 @ $0.8300$38.8K
15 more with Pro →